← stocks-llm Find companies like QSI →

Quantum-Si Inc (QSI)

Health Care · Proteomics instrumentation and consumables · Nasdaq

A proteomics instrumentation and consumables company bringing massively parallel single-molecule protein sequencing to researchers and clinicians through its Platinum platform, with a next-generation Proteus system in development.

What Quantum-Si Inc does

Quantum-Si is a life sciences company developing single-molecule detection platforms for proteomics research. The company provides next-generation protein sequencing (NGPS) technology enabling researchers and clinicians to analyze the proteome (the full set of proteins in a cell) in a massively parallel fashion rather than sequentially. Its current offerings include the Platinum NGPS line of instruments, analysis software, and consumable kits, with the next-generation Proteus platform anticipated to launch by end of 2026.

Themes: ["proteomics research","protein sequencing","single-molecule detection","biomarker discovery","life sciences instrumentation","consumables and reagents"]

Fundamentals

Ask why QSI looks like this →

Key risks (from latest filing)

["Proteus platform delay or failure to launch by end of 2026 or without promised customer-focused capabilities could materially impact market credibility and long-term financial success","Significant revenue decline (down 46% YoY) and deeply negative net margin (-5606%) indicate severe financial stress and limited path to profitability","New product launches and pending Proteus announcement may slow customer purchasing decisions for existing Platinum instruments and consumables, impacting near-term revenue"]

See QSI's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-10.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.